Continuous use, combined with lifestyle interventions such as diet and exercise, is necessary to maintain weight loss
Take 1 packet or capful daily as needed
During 1,414,144 person-years of follow-up, cholangiocarcinoma occurred among 222 patients with use of DPP4 inhibitors (incidence rate, 26 per 100,000 patient-years) and among 128 patients with use of sulfonylureas (incidence rate, 23 per 100,000 patient-years)
98,147 users of GLP1-RA and 2,488,303 users of DPP-4i were followed up with the median follow-up among users of GLP1-RA ranging from 1.8 to 3.0 years
Reflux symptoms often peak during dose escalation weeks 1-3 and naturally resolve within 4-8 weeks as your digestive system adapts to slower gastric emptying
Retatrutide The Horizon As of today, retatrutide is not yet available to the public